Annual Gross Profit
$20.75 M
-$3.58 M-14.73%
30 April 2024
Summary:
Champions Oncology annual gross profit is currently $20.75 million, with the most recent change of -$3.58 million (-14.73%) on 30 April 2024. During the last 3 years, it has risen by +$1.16 million (+5.92%). CSBR annual gross profit is now -18.54% below its all-time high of $25.48 million, reached on 30 April 2022.CSBR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$6.99 M
+$237.00 K+3.51%
31 July 2024
Summary:
Champions Oncology quarterly gross profit is currently $6.99 million, with the most recent change of +$237.00 thousand (+3.51%) on 31 July 2024. Over the past year, it has increased by +$2.03 million (+41.05%). CSBR quarterly gross profit is now at all-time high.CSBR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$22.87 M
+$2.11 M+10.18%
31 July 2024
Summary:
Champions Oncology TTM gross profit is currently $22.87 million, with the most recent change of +$2.11 million (+10.18%) on 31 July 2024. Over the past year, it has increased by +$2.23 million (+10.79%). CSBR TTM gross profit is now -15.23% below its all-time high of $26.97 million, reached on 31 October 2022.CSBR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.7% | +41.0% | +10.8% |
| 3 y3 years | +5.9% | +13.2% | -0.3% |
| 5 y5 years | +62.1% | +86.7% | +73.9% |
CSBR Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.5% | +5.9% | at high | +67.6% | -15.2% | +15.9% |
| 5 y | 5 years | -18.5% | +62.1% | at high | +88.6% | -15.2% | +73.9% |
| alltime | all time | -18.5% | +5231.1% | at high | +4728.5% | -15.2% | >+9999.0% |
Champions Oncology Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $6.99 M(+3.5%) | $22.87 M(+10.2%) |
| Apr 2024 | $20.75 M(-14.7%) | $6.75 M(+61.9%) | $20.75 M(+5.2%) |
| Jan 2024 | - | $4.17 M(-15.8%) | $19.73 M(-4.4%) |
| Oct 2023 | - | $4.96 M(+1.6%) | $20.64 M(-8.4%) |
| July 2023 | - | $4.88 M(-14.9%) | $22.52 M(-7.5%) |
| Apr 2023 | $24.34 M(-4.5%) | $5.73 M(+13.0%) | $24.34 M(-3.7%) |
| Jan 2023 | - | $5.07 M(-25.8%) | $25.26 M(-6.4%) |
| Oct 2022 | - | $6.84 M(+2.2%) | $26.97 M(+2.5%) |
| July 2022 | - | $6.69 M(+0.6%) | $26.31 M(+3.3%) |
| Apr 2022 | $25.48 M(+30.0%) | $6.66 M(-1.9%) | $25.48 M(+8.2%) |
| Jan 2022 | - | $6.79 M(+9.9%) | $23.54 M(+2.6%) |
| Oct 2021 | - | $6.18 M(+5.5%) | $22.94 M(+8.0%) |
| July 2021 | - | $5.86 M(+24.1%) | $21.24 M(+8.4%) |
| Apr 2021 | $19.59 M(+29.6%) | $4.72 M(-23.7%) | $19.59 M(+5.5%) |
| Jan 2021 | - | $6.19 M(+38.4%) | $18.58 M(+8.8%) |
| Oct 2020 | - | $4.47 M(+6.2%) | $17.08 M(+4.5%) |
| July 2020 | - | $4.21 M(+13.6%) | $16.35 M(+8.1%) |
| Apr 2020 | $15.12 M(+18.1%) | $3.71 M(-20.9%) | $15.12 M(+1.9%) |
| Jan 2020 | - | $4.69 M(+25.2%) | $14.83 M(+12.8%) |
| Oct 2019 | - | $3.74 M(+25.4%) | $13.15 M(+4.0%) |
| July 2019 | - | $2.98 M(-12.6%) | $12.64 M(-1.2%) |
| Apr 2019 | $12.80 M(+32.1%) | $3.42 M(+13.9%) | $12.80 M(+11.4%) |
| Jan 2019 | - | $3.00 M(-7.4%) | $11.49 M(+3.5%) |
| Oct 2018 | - | $3.24 M(+3.2%) | $11.10 M(+6.6%) |
| July 2018 | - | $3.14 M(+49.2%) | $10.41 M(+7.8%) |
| Apr 2018 | $9.69 M(+69.7%) | $2.11 M(-19.3%) | $9.66 M(+11.0%) |
| Jan 2018 | - | $2.61 M(+2.3%) | $8.70 M(+20.0%) |
| Oct 2017 | - | $2.55 M(+6.6%) | $7.25 M(+4.3%) |
| July 2017 | - | $2.39 M(+108.1%) | $6.95 M(+21.8%) |
| Apr 2017 | $5.71 M(+128.7%) | $1.15 M(-0.9%) | $5.71 M(+12.9%) |
| Jan 2017 | - | $1.16 M(-48.6%) | $5.05 M(+16.4%) |
| Oct 2016 | - | $2.25 M(+96.5%) | $4.34 M(+42.5%) |
| July 2016 | - | $1.15 M(+131.7%) | $3.05 M(+24.4%) |
| Apr 2016 | $2.50 M(+102.9%) | $495.00 K(+11.0%) | $2.45 M(-17.7%) |
| Jan 2016 | - | $446.00 K(-53.5%) | $2.98 M(+24.8%) |
| Oct 2015 | - | $960.00 K(+74.9%) | $2.39 M(+50.2%) |
| July 2015 | - | $549.00 K(-46.3%) | $1.59 M(+29.2%) |
| Apr 2015 | $1.23 M(-76.7%) | $1.02 M(-800.7%) | $1.23 M(+9.2%) |
| Jan 2015 | - | -$146.00 K(-189.6%) | $1.13 M(-66.3%) |
| Oct 2014 | - | $163.00 K(-14.2%) | $3.34 M(-19.1%) |
| July 2014 | - | $190.00 K(-79.3%) | $4.13 M(-21.9%) |
| Apr 2014 | $5.29 M | $919.00 K(-55.6%) | $5.29 M(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2014 | - | $2.07 M(+117.0%) | $4.65 M(+9.2%) |
| Oct 2013 | - | $953.00 K(-29.4%) | $4.26 M(+14.9%) |
| July 2013 | - | $1.35 M(+375.0%) | $3.71 M(+23.8%) |
| Apr 2013 | $3.00 M(+33.1%) | $284.00 K(-83.0%) | $3.00 M(+17.0%) |
| Jan 2013 | - | $1.68 M(+317.7%) | $2.56 M(+31.1%) |
| Oct 2012 | - | $401.00 K(-36.9%) | $1.95 M(-11.7%) |
| July 2012 | - | $635.00 K(-520.5%) | $2.21 M(-4.2%) |
| Apr 2012 | $2.25 M(-33.3%) | -$151.00 K(-114.2%) | $2.31 M(-25.6%) |
| Jan 2012 | - | $1.07 M(+61.7%) | $3.10 M(-9.5%) |
| Oct 2011 | - | $660.00 K(-9.8%) | $3.43 M(+9.1%) |
| July 2011 | - | $732.00 K(+13.5%) | $3.14 M(-9.3%) |
| Apr 2011 | $3.37 M(+13.2%) | $645.00 K(-53.7%) | $3.46 M(-17.0%) |
| Jan 2011 | - | $1.39 M(+272.2%) | $4.17 M(+32.1%) |
| Oct 2010 | - | $374.00 K(-64.5%) | $3.16 M(-15.5%) |
| July 2010 | - | $1.05 M(-22.2%) | $3.74 M(+25.5%) |
| Apr 2010 | $2.98 M(+65.3%) | $1.35 M(+258.2%) | $2.98 M(+40.9%) |
| Jan 2010 | - | $378.00 K(-60.3%) | $2.11 M(+3.1%) |
| Oct 2009 | - | $952.00 K(+223.8%) | $2.05 M(+21.8%) |
| July 2009 | - | $294.00 K(-39.9%) | $1.68 M(-6.6%) |
| Apr 2009 | $1.80 M(+98.0%) | $489.00 K(+55.7%) | $1.80 M(+37.3%) |
| Jan 2009 | - | $314.00 K(-46.4%) | $1.31 M(+31.4%) |
| Oct 2008 | - | $585.60 K(+41.8%) | $998.60 K(+141.8%) |
| July 2008 | - | $413.00 K(+11.4%) | $413.00 K(-70.5%) |
| Apr 2008 | $910.00 K(-34.9%) | - | - |
| Apr 2004 | $1.40 M(-7.1%) | $370.90 K(+19.6%) | $1.40 M(+0.7%) |
| Jan 2004 | - | $310.20 K(-8.8%) | $1.39 M(-1.8%) |
| Oct 2003 | - | $340.10 K(-9.7%) | $1.41 M(-6.5%) |
| July 2003 | - | $376.60 K(+4.5%) | $1.51 M(+0.1%) |
| Apr 2003 | $1.50 M(-1.9%) | $360.50 K(+7.5%) | $1.51 M(-2.2%) |
| Jan 2003 | - | $335.40 K(-23.6%) | $1.55 M(-2.8%) |
| Oct 2002 | - | $438.90 K(+16.8%) | $1.59 M(+3.2%) |
| July 2002 | - | $375.70 K(-4.9%) | $1.54 M(-0.4%) |
| Apr 2002 | $1.53 M(-0.2%) | $395.20 K(+4.1%) | $1.55 M(-3.9%) |
| Jan 2002 | - | $379.80 K(-2.5%) | $1.61 M(+3.7%) |
| Oct 2001 | - | $389.40 K(+1.9%) | $1.55 M(+4.6%) |
| July 2001 | - | $382.20 K(-16.5%) | $1.48 M(-4.6%) |
| Apr 2001 | $1.54 M(+294.7%) | $457.70 K(+42.1%) | $1.55 M(+31.1%) |
| Jan 2001 | - | $322.10 K(+0.2%) | $1.19 M(+23.0%) |
| Oct 2000 | - | $321.30 K(-29.2%) | $964.20 K(+50.0%) |
| July 2000 | - | $453.60 K(+408.0%) | $642.90 K(+239.6%) |
| Apr 2000 | $389.30 K | $89.30 K(-10.7%) | $189.30 K(+89.3%) |
| Jan 2000 | - | $100.00 K | $100.00 K |
FAQ
- What is Champions Oncology annual gross profit?
- What is the all time high annual gross profit for Champions Oncology?
- What is Champions Oncology annual gross profit year-on-year change?
- What is Champions Oncology quarterly gross profit?
- What is the all time high quarterly gross profit for Champions Oncology?
- What is Champions Oncology quarterly gross profit year-on-year change?
- What is Champions Oncology TTM gross profit?
- What is the all time high TTM gross profit for Champions Oncology?
- What is Champions Oncology TTM gross profit year-on-year change?
What is Champions Oncology annual gross profit?
The current annual gross profit of CSBR is $20.75 M
What is the all time high annual gross profit for Champions Oncology?
Champions Oncology all-time high annual gross profit is $25.48 M
What is Champions Oncology annual gross profit year-on-year change?
Over the past year, CSBR annual gross profit has changed by -$3.58 M (-14.73%)
What is Champions Oncology quarterly gross profit?
The current quarterly gross profit of CSBR is $6.99 M
What is the all time high quarterly gross profit for Champions Oncology?
Champions Oncology all-time high quarterly gross profit is $6.99 M
What is Champions Oncology quarterly gross profit year-on-year change?
Over the past year, CSBR quarterly gross profit has changed by +$2.03 M (+41.05%)
What is Champions Oncology TTM gross profit?
The current TTM gross profit of CSBR is $22.87 M
What is the all time high TTM gross profit for Champions Oncology?
Champions Oncology all-time high TTM gross profit is $26.97 M
What is Champions Oncology TTM gross profit year-on-year change?
Over the past year, CSBR TTM gross profit has changed by +$2.23 M (+10.79%)